Detalles de la búsqueda
1.
SARS-CoV-2 infection in domestic rats after transmission from their infected owner
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-512053
2.
A mouse-adapted SARS-CoV-2 strain replicating in standard laboratory mice.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-451880
3.
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without Omicron breakthrough infection.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22277885
4.
The B1.351 and P.1 variants extend SARS-CoV-2 host range to mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-436013
5.
A measles-vectored COVID-19 vaccine induces long-term immunity and protection from SARS-CoV-2 challenge in mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-431630
6.
Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-429604
7.
A novel SARS-CoV-2 related coronavirus in bats from Cambodia
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-428212
8.
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-079608
9.
Introductions and early spread of SARS-CoV-2 in France
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-059576
10.
A new SARS-CoV-2 variant poorly detected by RT-PCR on nasopharyngeal samples, with high lethality
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21256690
11.
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4 and BA.5 in patients receiving monoclonal antibodies
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22278699
12.
Early phylodynamics analysis of the COVID-19 epidemics in France
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20119925
13.
Seroneutralization of Omicron BA.1 and BA.2 in patients receiving anti-SARS-CoV-2 monoclonal antibodies.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22272066
14.
Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-516888
15.
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-475248
16.
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-445838
17.
Identification of DAXX As A Restriction Factor Of SARS-CoV-2 Through A CRISPR/Cas9 Screen
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-442916
18.
Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-505985
19.
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-430472
20.
Immune escape of SARS-CoV-2 Omicron variant from mRNA vaccination-elicited RBD-specific memory B cells.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-473528